Related references
Note: Only part of the references are listed.Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii
Youfa Qin et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)
Comparison of mono- and combination antibiotic therapy for the treatment of Pseudomonas aeruginosa bacteraemia: A cumulative meta-analysis of cohort studies
Su Yu Tang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure
Deanna J. Buehrle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012
Latania K. Logan et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2017)
Tree-structured survival analysis of patients with Pseudomonas aeruginosa bacteremia: A multicenter observational cohort study
Young Kyung Yoon et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections
Kuan-Yin Lin et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies
Yu Zhang et al.
EMERGING MICROBES & INFECTIONS (2016)
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
Youn Jeong Kim et al.
BMC INFECTIOUS DISEASES (2014)
Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome
Su Jin Jeong et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae
Milena McLaughlin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa
Damien Fournier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing
David Skurnik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Prospective Multicenter Study of the Impact of Carbapenem Resistance on Mortality in Pseudomonas aeruginosa Bloodstream Infections
Carmen Pena et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
Ioannis A. Bliziotis et al.
PLOS ONE (2011)
Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis
Scott T. Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Low-dose β-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial
L. Gomez et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals
Jie Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Pseudomonas aeruginosa - a phenomenon of bacterial resistance
Tanya Strateva et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia
H. S. Cheong et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia:: An observational, multicenter study comparing monotherapy with combination antibiotic therapy
Jose Garnacho-Montero et al.
CRITICAL CARE MEDICINE (2007)
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients
C. Pena et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Invasive fungal infections: a review of epidemiology and management options
D. A. Enoch et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a teaching hospital in southern Brazil
AP Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials
M Paul et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward
C Peña et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Share Paper
